BENCHMARKING AIDS: 2006 YEAR END UPDATE – Pharmaceutical companies improve performance in certain areas

SRI and faith-based investors warn of continued failure to fully appreciate risks to industry from pediatric HIV and generalized HIV-TB-Malaria pandemics

Boston, MA – The Benchmarking AIDS report released by ICCR earlier this year finds that pharmaceutical companies’ response is still lacking in key areas including access to treatment for children and child-to-mother prevention.

Please click here for the full report.

For more information please contact: Lauren Compere, Director of Shareholder Advocacy, Boston Common Asset Management, (617) 720-5557, lcompere(at)

Back to News page